The stock of Dexcom Inc (DXCM) has seen a 7.32% increase in the past week, with a -31.50% drop in the past month, and a -41.77% decrease in the past quarter. The volatility ratio for the week is 3.14%, and the volatility levels for the past 30 days are at 4.48% for DXCM. The simple moving average for the last 20 days is -2.73% for DXCM’s stock, with a simple moving average of -34.76% for the last 200 days.
Is It Worth Investing in Dexcom Inc (NASDAQ: DXCM) Right Now?
The price-to-earnings ratio for Dexcom Inc (NASDAQ: DXCM) is above average at 47.13x, Company’s 36-month beta value is 1.18.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 8 as “overweight,” 7 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for DXCM is 394.61M, and currently, short sellers hold a 1.79% ratio of that floaft. The average trading volume of DXCM on August 19, 2024 was 5.02M shares.
DXCM) stock’s latest price update
Dexcom Inc (NASDAQ: DXCM)’s stock price has gone rise by 2.46 in comparison to its previous close of 74.65, however, the company has experienced a 7.32% increase in its stock price over the last five trading days. accesswire.com reported 2024-08-19 that LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ:DXCM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Analysts’ Opinion of DXCM
Many brokerage firms have already submitted their reports for DXCM stocks, with Robert W. Baird repeating the rating for DXCM by listing it as a “Neutral.” The predicted price for DXCM in the upcoming period, according to Robert W. Baird is $80 based on the research report published on July 26, 2024 of the current year 2024.
JP Morgan, on the other hand, stated in their research note that they expect to see DXCM reach a price target of $75, previously predicting the price at $145. The rating they have provided for DXCM stocks is “Neutral” according to the report published on July 26th, 2024.
Redburn Atlantic gave a rating of “Neutral” to DXCM, setting the target price at $130 in the report published on May 30th of the current year.
DXCM Trading at -23.31% from the 50-Day Moving Average
After a stumble in the market that brought DXCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.13% of loss for the given period.
Volatility was left at 4.48%, however, over the last 30 days, the volatility rate increased by 3.14%, as shares sank -31.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -33.68% lower at present.
During the last 5 trading sessions, DXCM rose by +7.30%, which changed the moving average for the period of 200-days by -13.91% in comparison to the 20-day moving average, which settled at $76.88. In addition, Dexcom Inc saw -38.36% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DXCM starting from Brown Michael Jon, who sale 652 shares at the price of $69.55 back on Jul 31 ’24. After this action, Brown Michael Jon now owns 66,249 shares of Dexcom Inc, valued at $45,347 using the latest closing price.
MICHAEL BROWN, the Officer of Dexcom Inc, proposed sale 652 shares at $69.55 during a trade that took place back on Jul 31 ’24, which means that MICHAEL BROWN is holding shares at $45,347 based on the most recent closing price.
Stock Fundamentals for DXCM
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.63 for the gross margin
The net margin for Dexcom Inc stands at 0.17. The total capital return value is set at 0.13. Equity return is now at value 29.41, with 9.79 for asset returns.
Based on Dexcom Inc (DXCM), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at 0.36. The debt to equity ratio resting at 1.01. The interest coverage ratio of the stock is 47.33.
Currently, EBITDA for the company is 916.7 million with net debt to EBITDA at 1.82. When we switch over and look at the enterprise to sales, we see a ratio of 8.22. The receivables turnover for the company is 3.94for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.82.
Conclusion
In a nutshell, Dexcom Inc (DXCM) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
